348 related articles for article (PubMed ID: 19522463)
41. Cyclopamine: inhibiting hedgehog in the treatment of psoriasis.
Meth MJ; Weinberg JM
Cutis; 2006 Sep; 78(3):185-8. PubMed ID: 17036662
[TBL] [Abstract][Full Text] [Related]
42. Design, synthesis, and biological evaluation of optimized phthalazine derivatives as hedgehog signaling pathway inhibitors.
Lu X; Peng Y; Wang C; Yang J; Bao X; Dong Q; Zhao W; Tan W; Dong X
Eur J Med Chem; 2017 Sep; 138():384-395. PubMed ID: 28688278
[TBL] [Abstract][Full Text] [Related]
43. Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclo- propyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydro-imidazo[1,5-a]pyrazine-7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, part 2.
Kinzel O; Alfieri A; Altamura S; Brunetti M; Bufali S; Colaceci F; Ferrigno F; Filocamo G; Fonsi M; Gallinari P; Malancona S; Hernando JI; Monteagudo E; Orsale MV; Palumbi MC; Pucci V; Rowley M; Sasso R; Scarpelli R; Steinkühler C; Jones P
Bioorg Med Chem Lett; 2011 Aug; 21(15):4429-35. PubMed ID: 21737263
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of vitamin D3 A-ring analogues as Hedgehog pathway inhibitors.
Banerjee U; Ghosh M; Kyle Hadden M
Bioorg Med Chem Lett; 2012 Feb; 22(3):1330-4. PubMed ID: 22226657
[TBL] [Abstract][Full Text] [Related]
45. Effect of the Hedgehog-inhibitor cyclopamine on mice with osteosarcoma pulmonary metastases.
Warzecha J; Dinges D; Kaszap B; Henrich D; Marzi I; Seebach C
Int J Mol Med; 2012 Mar; 29(3):423-7. PubMed ID: 22138977
[TBL] [Abstract][Full Text] [Related]
46. Hydroxylated cyclopamine analogues from Veratrum californicum and their hedgehog pathway inhibiting activity.
Chianese G; Lopatriello A; Sirignano C; Andreani A; Gambini A; De Combarieu E; Stornaiuolo M; Taglialatela-Scafati O
Bioorg Med Chem; 2023 Apr; 84():117265. PubMed ID: 37001245
[TBL] [Abstract][Full Text] [Related]
47. Cyclopamine, a naturally occurring alkaloid, and its analogues may find wide applications in cancer therapy.
Ma H; Li HQ; Zhang X
Curr Top Med Chem; 2013; 13(17):2208-15. PubMed ID: 23978132
[TBL] [Abstract][Full Text] [Related]
48. Development of a monoclonal antibody-based ELISA for the hedgehog inhibitors cyclopamine and KAAD-cyclopamine.
Lee ST; Panter KE; Gardner DR; Green BT; Welch KD; Zhang J; Chang CW
J Pharm Biomed Anal; 2012 Jul; 66():282-6. PubMed ID: 22516681
[TBL] [Abstract][Full Text] [Related]
49. Discovery of pyrrolo[3,2-c]quinoline-4-one derivatives as novel hedgehog signaling inhibitors.
Ohashi T; Oguro Y; Tanaka T; Shiokawa Z; Shibata S; Sato Y; Yamakawa H; Hattori H; Yamamoto Y; Kondo S; Miyamoto M; Tojo H; Baba A; Sasaki S
Bioorg Med Chem; 2012 Sep; 20(18):5496-506. PubMed ID: 22910224
[TBL] [Abstract][Full Text] [Related]
50. Discovery of novel 4-(2-pyrimidinylamino)benzamide derivatives as highly potent and orally available hedgehog signaling pathway inhibitors.
Xin M; Zhang L; Jin Q; Tang F; Wen J; Gu L; Cheng L; Zhao Y
Eur J Med Chem; 2016 Mar; 110():115-25. PubMed ID: 26820554
[TBL] [Abstract][Full Text] [Related]
51. A new cyclopamine glucuronide prodrug with improved kinetics of drug release.
Renoux B; Legigan T; Bensalma S; Chadéneau C; Muller JM; Papot S
Org Biomol Chem; 2011 Dec; 9(24):8459-64. PubMed ID: 22042246
[TBL] [Abstract][Full Text] [Related]
52. Three new alkaloids from Veratrum grandiflorum Loes with inhibition activities on Hedgehog pathway.
Gao L; Chen F; Li X; Xu S; Huang W; Ye Y
Bioorg Med Chem Lett; 2016 Oct; 26(19):4735-4738. PubMed ID: 27567371
[TBL] [Abstract][Full Text] [Related]
53. Antitumor activity of extracts and compounds from the rhizomes of Veratrum dahuricum.
Tang J; Li HL; Shen YH; Jin HZ; Yan SK; Liu RH; Zhang WD
Phytother Res; 2008 Aug; 22(8):1093-6. PubMed ID: 18570211
[TBL] [Abstract][Full Text] [Related]
54. 1-amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity.
Miller-Moslin K; Peukert S; Jain RK; McEwan MA; Karki R; Llamas L; Yusuff N; He F; Li Y; Sun Y; Dai M; Perez L; Michael W; Sheng T; Lei H; Zhang R; Williams J; Bourret A; Ramamurthy A; Yuan J; Guo R; Matsumoto M; Vattay A; Maniara W; Amaral A; Dorsch M; Kelleher JF
J Med Chem; 2009 Jul; 52(13):3954-68. PubMed ID: 19469545
[TBL] [Abstract][Full Text] [Related]
55. AT-101 inhibits hedgehog pathway activity and cancer growth.
Wang J; Peng Y; Liu Y; Yang J; Huang M; Tan W
Cancer Chemother Pharmacol; 2015 Sep; 76(3):461-9. PubMed ID: 26113054
[TBL] [Abstract][Full Text] [Related]
56. Paracrine Hedgehog signaling in cancer.
Theunissen JW; de Sauvage FJ
Cancer Res; 2009 Aug; 69(15):6007-10. PubMed ID: 19638582
[TBL] [Abstract][Full Text] [Related]
57. Biology-driven diversity: concept of focused diversity.
Kiselyov AS
Chem Biol Drug Des; 2006 Jul; 68(1):67-9. PubMed ID: 16923028
[No Abstract] [Full Text] [Related]
58. Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclopropyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydroimid azo[1,5-a]pyrazine-7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, part 1.
Malancona S; Altamura S; Filocamo G; Kinzel O; Hernando JI; Rowley M; Scarpelli R; Steinkühler C; Jones P
Bioorg Med Chem Lett; 2011 Aug; 21(15):4422-8. PubMed ID: 21737272
[TBL] [Abstract][Full Text] [Related]
59. New developments in the discovery of small molecule Hedgehog pathway antagonists.
Tremblay MR; McGovern K; Read MA; Castro AC
Curr Opin Chem Biol; 2010 Jun; 14(3):428-35. PubMed ID: 20399136
[TBL] [Abstract][Full Text] [Related]
60. Self-renewal of acute lymphocytic leukemia cells is limited by the Hedgehog pathway inhibitors cyclopamine and IPI-926.
Lin TL; Wang QH; Brown P; Peacock C; Merchant AA; Brennan S; Jones E; McGovern K; Watkins DN; Sakamoto KM; Matsui W
PLoS One; 2010 Dec; 5(12):e15262. PubMed ID: 21203400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
